A single blood test screening for a shared cancer signal across 50+ cancer types
Galleri is a multi-cancer early detection (MCED) test developed by GRAIL. Rather than looking for one cancer at a time, it analyses methylation patterns in cell-free DNA (cfDNA) in the bloodstream to identify a signal associated with cancer.
When a cancer signal is detected, the test predicts the most likely cancer signal origin to help guide further diagnostic investigation.
Its particular value is that many of these cancers have no recommended screening programme in the UK. Galleri is designed to complement — not replace — established programmes such as breast, cervical and bowel screening.
Screening is currently recommended for only a relatively small number of cancer types in the UK, including breast, cervical, bowel and targeted lung cancer screening. Many cancers are not found until symptoms appear.
The Galleri test offers an additional approach:
50+ cancer types
Screened for a shared cancer signal from a single blood sample.
99.6% specificity
Fewer than 1 in 200 people without cancer will receive a false-positive result.
Cancer Signal Origin
When a cancer signal is detected, Galleri predicts the most likely tissue of origin to help guide further diagnostic investigation.
Clinician-led at The Wright Practice
Every test is considered in the context of your individual health, cancer risk and existing screening, with doctor-led interpretation and follow-up.

The test looks for patterns in cell-free DNA circulating in the bloodstream.
The process involves:
Galleri is a screening aid, not a diagnostic test. A positive result needs diagnostic confirmation; a negative result does not rule out cancer.

The Galleri® test is recommended for use in adults with an elevated risk of cancer, such as those with a family history of cancer or those over 50 years old.
This may also include individuals with a personal history of cancer, smokers or former smokers, and anyone wishing to take a proactive approach to their health.
Your doctor at The Wright Practice will help assess whether the test is appropriate for you.
Galleri is not recommended for people who are pregnant, aged 21 or younger, or undergoing active cancer treatment.

These include many cancers for which there is currently no recommended UK screening programme.
Examples include cancers affecting the:
Chest & airway: lung, head & neck and oesophageal cancers.
Digestive system: colon & rectum, pancreatic, stomach, liver, bile duct, gallbladder and anus.
Women’s health: breast, ovarian, cervical and uterine cancers.
Blood & other: lymphoma, leukaemia, plasma cell myeloma, melanoma, bladder and upper urinary tract — and more than 50 in total.

A “No Cancer Signal Detected” result means that the test did not find a cancer signal in your blood at the time of testing.
This can be a reassuring result, but it cannot guarantee you are cancer-free — very early-stage cancers may not yet shed detectable DNA.
This result does not predict whether you will develop cancer in the future.
You should continue with all routine cancer screening recommended for you and seek medical advice if you develop new or persistent symptoms.
Receiving a “Cancer Signal Detected” result is not a cancer diagnosis.
It means the test has found a signal that may be associated with cancer.
The Wright Practice will contact you promptly, explain the result clearly and arrange appropriate follow-up diagnostic investigations to determine whether cancer is present.
When a cancer signal is detected, Galleri also provides a Cancer Signal Origin prediction to help guide the diagnostic evaluation.
This is an important part of deciding whether the test is right for you.
A ‘No Signal Detected’ result does not mean you are cancer-free. Galleri looks for a signal associated with cancer in the bloodstream, but no test can detect every cancer.
It does not replace NHS screening. If you are due a mammogram, bowel-screening test, cervical screening or lung screening, you should continue with it.
It does not investigate symptoms. If something is worrying you, a doctor’s appointment is the right first step, not this test.
The impact of the test on cancer survival is not currently known. It has not yet been established whether using Galleri to detect cancer improves survival.

At The Wright Practice, Galleri is not simply an isolated blood test.
Your doctor will review your general health, personal and family cancer history, previous cancer diagnoses, smoking history, current symptoms and existing screening.
We will also consider whether conventional cancer screening or targeted investigation is more appropriate.
A blood sample is collected by our clinical team and sent for Galleri analysis.
No fasting or complex preparation is required.
Your result is reviewed by one of our doctors and interpreted in the context of your overall clinical picture.
Results can usually be expected within 14 working days.
If no cancer signal is detected, we will discuss which routine screening and health surveillance should continue.
If a cancer signal is detected, we will contact you promptly and coordinate the appropriate diagnostic pathway. This may include imaging, endoscopy or specialist referral.
Our role is not simply to provide the blood test. It is to help you understand what the result means and navigate what happens next.

Galleri should be used in addition to, not instead of, established cancer screening.
Depending on your age, sex and individual risk, your wider screening programme may include breast screening, cervical screening, bowel cancer screening, prostate assessment, targeted lung screening or additional surveillance based on your personal or family history.
Galleri also differs from genetic testing. Galleri looks for a signal that may indicate that cancer is currently present; genetic testing can identify inherited variants associated with an increased future risk of developing certain cancers.
The NHS-Galleri trial involved approximately 142,000 adults aged 50–77, who received annual Galleri testing for three years and were followed for an additional year.
The study’s primary goal was to determine whether adding Galleri to standard screening could reduce the number of stage III and IV cancers diagnosed after three years.
While there was a favourable trend, a statistically significant reduction in combined stage III and IV diagnoses was not observed for the group of 12 specified cancers, meaning the trial did not meet its primary endpoint.
There were, however, several encouraging secondary findings.
Adding Galleri to standard screening resulted in more than four times as many cancers being detected through screening compared with standard screening alone.
In the third year of annual screening, there were 26% fewer stage IV diagnoses among the group of 12 specified cancers in people receiving Galleri in addition to standard screening.
The trial also reported fewer cancers diagnosed following an emergency presentation.
These findings are encouraging, but they need to be interpreted alongside the fact that the study’s primary endpoint was not met. Longer-term evidence will be important in determining the effect of multi-cancer early detection testing on cancer outcomes and survival.

In September 2026, an independent advisory committee to the US Food and Drug Administration (FDA) voted in favour of approval of the Galleri® test.
The committee considered Galleri’s safety, effectiveness and overall benefit-risk profile for screening adults aged 50 years and over.
The committee voted:
10–0 in support of Galleri’s safety
6–4 in support of its effectiveness
7–2, with one abstention, that its benefits outweigh its risks
The advisory committee’s favourable recommendation represents an important step in the FDA’s Premarket Approval review process.
However, Galleri has not yet received FDA approval. The advisory committee provides independent expert advice to the FDA, and the FDA will consider its recommendations alongside the wider evidence before making its final regulatory decision.
Galleri testing at The Wright Practice combines advanced multi-cancer screening with careful clinical assessment, pre-test counselling and doctor-led follow-up.
The Wright Practice
101 Harley Street London W1G 6AH
0207 139 1833
info@thewrightpractice.com
Galleri is a screening test and is not diagnostic. It does not detect every cancer, and false-positive and false-negative results can occur. A Cancer Signal Detected result requires further diagnostic investigation. A No Cancer Signal Detected result does not exclude cancer. Galleri must not replace routine cancer screening or the investigation of symptoms.
Wow! Dr. Dan was extremely knowledgeable and attentive to my health and well being. I’m so glad to have found him!
I have been going to Dr Wright for a number of years now. He is highly knowledgeable, compassionate, open minded and efficient, I couldn’t recommend him highly enough
I have been a patient of Doctor Dan for some time and continue to consult with him despite having left the UK. Dan has the enthusiasm and energy of a young man, whilst taking the holistic “physician” approach of an old school family doctor, equipped with the most modern insights and technology.
Dr Jain was great. Expert knowledge with practical advice
No. The Galleri® test is a complementary tool and not a replacement for NHS screening programmes such as bowel, breast or cervical screening.
We recommend continuing with all age-appropriate NHS screening alongside the Galleri test.
No. Galleri looks for DNA markers associated with a cancer signal that may be present now. It does not assess your genome to predict your future risk of developing cancer.
Yes. Galleri may be considered in people with a previous history of cancer, but it does not replace any surveillance or follow-up recommended by your oncologist.
The Galleri test has a specificity of 99.6%, meaning fewer than 1 in 200 people without cancer will receive a false-positive result.
Sensitivity — the ability to detect cancer when it is present — varies according to the type and stage of cancer.
A No Cancer Signal Detected result therefore does not provide an absolute all-clear.
A Cancer Signal Detected result is not a cancer diagnosis.
We will contact you promptly, explain the result and arrange appropriate diagnostic investigations to determine whether cancer is present.
A No Cancer Signal Detected result can be reassuring, but it does not rule out cancer.
You should continue routine NHS or private cancer screening, remain aware of any new or persistent symptoms and continue any individual surveillance recommended because of your personal or family history.
Book online | Call: +44 (0)207 139 1833 | Email: info@thewrightpractice.com
101 Harley Street, London, W1G 6AH




Rated ★ ★ ★ ★ ★ from 197 Reviews